Show simple item record

dc.contributor.authorAdimora, AA
dc.contributor.authorRamirez, C
dc.contributor.authorAuerbach, JD
dc.contributor.authorAral, SO
dc.contributor.authorHodder, S
dc.contributor.authorWingood, G
dc.contributor.authorEl-Sadr, W
dc.contributor.authorBukusi, EA
dc.contributor.authorHIV Prevention Trials Network Women at Risk Committee.
dc.date.accessioned2013-10-07T11:14:12Z
dc.date.available2013-10-07T11:14:12Z
dc.date.issued2013
dc.identifier.citationJ Acquir Immune Defic Syndr.2013 Jul;63 Suppl 2:S168-73en
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/23764631
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/57427
dc.description.abstractAlthough the number of new infections has declined recently, women still constitute almost half of the world's 34 million people with HIV infection, and HIV remains the leading cause of death among women of reproductive age. Prevention research has made considerable progress during the past few years in addressing the biological, behavioral, and social factors that influence women's vulnerability to HIV infection. Nevertheless, substantial work still must be performed to implement scientific advancements and to resolve many questions that remain. This article highlights some of the recent advances and persistent gaps in HIV prevention research for women and outlines key research and policy priorities.en
dc.language.isoenen
dc.publisherWolters Kluweren
dc.titlePreventing HIV infection in women.en
dc.typeArticleen
local.publisherDivision of Infectious Diseases, UNC School of Medicine, Chapel Hill, NC 27599-7030, USAen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record